chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Vaccines administered Friday, 8-10.  Fevers began Sunday evening on 8-12.  Fevers have been inconsistent throughout the course of the weeks actually clearing for days and returning with a tendency to spike in the p.m. and remain low grade and unnoticed throughout the day.  Fevers had been noted at 101.6 under the arm under Tylenol control.  Diarrhea was inconsistently noted.  Weight maintained from well-check to two week lapse.  Appetite substantial with regression onto breast from usual table feedings.  Monday, 8-13 small, defined, red spots began to be seen around mouth and by Tuesday evening, 8-14 the trunk had small defined red spots and progressed to lower extremities with fainter coloring.  By Wednesday, 8-15 physician recommended treatment for hives with benadryl and claritin until clear.  Noted rash clearing over next few days and discontinued meds on Friday, 8-17.  Saturday, 8-18 she was noted by several acquiantances as having odd behavior and a full day without rest.  (?possible seizure spell)  Fever returned by Saturday afternoon and was controlled by Tylenol and Motrin.  P.M. spiking was again noted.  Sunday, 8-19 rash was seen returning on face.  Monday morning, 8-20 within one hour the rash had been noted as spreading behind ears to entire trunk and throughout lower extremities.  Again, the moderate-severe rash was small, defined red spots.  Seen by physician and again diagnosed as possible hives.  Physician did state viral infection more likely, but continue to treat  for hives with Bendadryl and Claritin.  As of today, Tuesday, 8-21 even with benadryl influence she is seen with a progressive severe covering of more confluent large raised rash groupings throughout face, neck, behind ears, trunk, genital area, and moderately throughout lower extremities.
Description :  progressive fatigue, cognitive loss, anhedonia, myalgias, arthralgias after each anthrax vaccine Comment: med records requested  Symptom:  Fatigue Malaise > 60 Days Start: 10/7/2003 Symptom:  Memory Loss, short term Start:  10/7/2003 Symptom:  Joint Pain, multiple joints Start: 10/7/2003 Symptom:  Muscle Pain Start:  10/7/2003
global headache which began around 7 pm on injection day, still present  fever, chills, fatigue on injection day around 7pm which resolved after a day  new onset left leg numbness and pallor on 4/12-4/13. Not actively pulseless here in ED but patient reported diminished pulse
arm near elbow got swollen size of a golfball, did biopsy, it is cancer, now receiving care at cancer center since the immunization
25 yo F with presented for Janssen (Johnson and Johnson) Covid-19 vaccination at the drive up clinic a on 3/10/21.  Patient is part of group 3.  Patient with no allergy history and no history of previous allergy reactions to vaccinations.  Patient given 0.5ml Janssen Covid19 vaccination in left deltoid at 1407 (Lot # 1802070).  Patient assigned to be observed for 5 minutes.  After observation(?), while moving her car to in the parking area/clinic, the patient stopped at traffic control to tell them they did not feel well. Traffic controller told patient to pull over to the side.  Simultaneously the car proceeded to move forward, over the curb and hit the stop sign. Patient was alert but c/o dizziness when staff arrived at vehicle to assess. EMS called.  No other information available for further followup.   Vasovagal event?  No medical records are available for this patient
Shingles vaccine caused a very bad headache, 99.2 fever,  aches and pain at the sight.
he was dreaming [after taking the Moderna vaccine]; This spontaneous case was reported by a patient and describes the occurrence of ABNORMAL DREAMS (he was dreaming [after taking the Moderna vaccine]) in an adult male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ABNORMAL DREAMS (he was dreaming [after taking the Moderna vaccine]). At the time of the report, ABNORMAL DREAMS (he was dreaming [after taking the Moderna vaccine]) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  It was reported that he even had to go to the church to ask why he was dreaming [after taking the Moderna vaccine]. The church would respond to him, some people are still like that.  Treatment information was not provided.
feet swelling; feet swelling and pain; This is a spontaneous report received from a contactable reporter (Other HCP). The reporter is the patient.  A 31 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 28Aug2021 10:30 (Lot number: FF2588) at the age of 31 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Vitamin D deficiency" (unspecified if ongoing); "penicillin" (unspecified if ongoing), notes: known allergies: penicillin. The patient's concomitant medications were not reported. The following information was reported: PERIPHERAL SWELLING (non-serious) with onset 28Aug2021 14:30, outcome "not recovered", described as "feet swelling"; PAIN IN EXTREMITY (non-serious) with onset 28Aug2021 14:30, outcome "not recovered", described as "feet swelling and pain". Therapeutic measures were not taken as a result of peripheral swelling, pain in extremity.  Additional information: Bilateral feet swelling and pain, Swelling is medial, just posterior to feet arches. No other vaccine in four weeks, no Covid prior vaccination and no Covid tested post vaccination.  Follow-up attempts are completed. No further information is expected.
Vaccination Failure (28/Sep/2021, covid test result, Positive); covid test result, Positive; Inappropriate schedule of vaccine administered; This is a spontaneous report from a contactable Consumer. This 52-year-old male Consumer reported for himself that:  A 52-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EM9810) via unspecified route of administration in left arm on 02Sep2021 (at the age of 52-year-old) as dose 2, single for COVID-19 immunization. The patient other medical history: one. Patient don't have known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. The patient was tested for COVID-19 post vaccination. Concomitant medication was not reported. The patient received other medications within 2 weeks of vaccination: Blood pressure (Other medications in two weeks: Blood pressure). Patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: El1283) via unspecified route of administration in left arm on 20Jan2021 as dose 1, single for COVID-19 immunization. On 28Sep2021 the patient experienced Drug ineffective, covid test result, positive and inappropriate schedule of vaccine administered. Patient reported on 01Mar2021 we are not sure, but all tests were negative triggering Lichen Planus triggering the loss of all my hand finger nails and feet fingernails. And all these were in Mar2021.Patient received treatment of steroid shots and outcome was not recovered. Patient underwent lab tests and procedures which included sars-cov-2 (Nasal Swab) test negative on 11May2021, sars-cov-2 (Nasal Swab) test positive on 28Sep2021. Patient received treatment for events. The outcome of the events was not recovered.  No follow-up attempts possible. No further information expected.
Vaccine was administered and within 30 seconds patient fainted.  Patient recovered quickly with minimal intervention. Patient was observed in pharmacy for approximately 30 minutes after administration until he indicated he was feeling well enough to leave.
rash; Inappropriate age at vaccine administration; This case was reported by a other health professional via call center representative and described the occurrence of injection site rash in a 49-year-old male patient who received DTPa (Infanrix) (batch number J947T, expiry date 30th May 2021) for prophylaxis.   On an unknown date, the patient received Infanrix. On an unknown date, unknown after receiving Infanrix, the patient experienced injection site rash and adult use of a child product. On an unknown date, the outcome of the injection site rash and adult use of a child product were unknown.   It was unknown if the reporter considered the injection site rash to be related to Infanrix.  Additional details were provided as follows: The medical assistant reported that Infanrix was inadvertently administered to the 49 years old patient, which led to adult use of a child product. The Patient developed rash on arm of injection. The reporter consented to follow up.
Headache starting same day and continuing on and off for 36 hours. Fever peaking at 100.5, full body ache, and chills, all beginning the next morning and lasting all of the next day.
pt recv vax 30MAR98 & 9APR98 pt devel a rash that started @ the inj site & disseminated generally over trunk & extremities;
This case was reported by a pharmacist via call center representative and described the occurrence of erythema of extremities in a male patient who received Influenza vaccine Quadrivalent. On an unknown date, the patient received Influenza vaccine Quadrivalent. On an unknown date, unknown after receiving Influenza vaccine Quadrivalent, the patient experienced erythema of extremities and swelling arm. The patient was treated with Antibiotics Therapy (Unknown). On an unknown date, the outcome of the erythema of extremities and swelling arm were not reported. It was unknown if the reporter considered the erythema of extremities and swelling arm to be related to Influenza vaccine Quadrivalent. Additional details were provided as follows: The age at vaccination was not reported. The patient received an unspecified influenza injection years before the reporting date. This case has been linked with case US2018077566, reported by same reporter for same patient.
DIZZINESS AND NAUSEA/VOMITING 1 HOUR AFTER RECEIVING DOSE
Patient had Tdap vaccination (L deltoid) on June 22. On June 23 (L) deltoid started swelling, per patient report swelling was 4" x 3" in diameter. States it was swollen and sore. On June 24 patient awoke w/a red, itchy rash on hips, buttocks, mid section, shoulders, arms and groin. Reports the rash resolved near end of day on June 25 after taking antihistamine.
Presyncopal with hypertension and tachycardia . Resolved after observation . Was given oral Benadryl
Chills; Body malaise/muscle pain on affected area/not feeling well; Runny nose; Booster; This is a spontaneous report from a contactable nurse, the patient. A 36-year-old non-pregnant female patient received the booster dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an intramuscular route of administration in the right arm on 27Sep2021 at 14:15 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously received the first and second dose of covid-19 vaccine (MANUFACTURER UNKNOWN) via an unspecified route of administration on unknown date as a single dose for COVID-19 immunisation. On 27Sep2021 at 23:00, the patient experienced chills, body malaise, runny nose, muscle pain on affected area. The patient was not feeling well after the COVID shot booster. Even she took Tylenol and still her symptoms did not go away. This is first time to experience this kind of side effects. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of events and included treatment with paracetamol (TYLENOL). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chills, runny nose and body malaise/muscle pain on affected area/not feeling well after the COVID shot booster was not resolved at the time of this report.  The lot number for BNT162b2 was not provided and will be requested during follow up.
FEVER; INJECTION SITE PAIN IN LEFT ARM; PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE; OFF LABEL USE; This spontaneous report received from a pharmacist concerned an adolescent female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included unknown.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 03-JUN-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 03-JUN-2021, the subject experienced product administered to subject of inappropriate age. On 03-JUN-2021, the subject experienced off label use. On 05-JUN-2021, the subject experienced fever. On 05-JUN-2021, the subject experienced injection site pain in left arm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the fever, injection site pain in left arm, product administered to patient of inappropriate age and off label use was not reported. This report was non-serious.
Rashes and redness in both wrist, arms, neck TX by Dr. Benadryl 12.5mg/5ml, 10 Ml Given po ordered STAT> 1500 Another rash developing in L index finger. Remind pt to wait for another 30 mins.
patient covid +,on day 13 since identified. received covid 19 vaccine 19 hours prior to fever presentation. patient to receive full medical work up to rule out other medical contributions for fever. Confusion, Fever, HYPERtension & FEVER 101.5 fahrenheit, weakness
Dizziness and vomiting after no major symptoms all day. I should note I did receive a one-hour deep tissue massage at approximately 3:30 PM and felt symptoms afterwards.
Information has been received from a physician concerning a patient who on an unspecified date was vaccinated with the third dose of RECOMBIVAX HB (Lot #, expire date and route not reported). On an unspecified date, antibody titers were drawn 2 to 7 months after the third dose was administered. The patient did not seroconvert after getting the RECOMBIVAX HB series. Physician stated he thought that there was a pretty high percentage of patients that did not seroconvert (reported as 3 of 8). The patient did not experienced any adverse effects post vaccination. At the time of the report, the outcome of the patient was unknown. Additional information has been requested. This is one of several reports received from the same source.
I tested positive for COVID-19 on 12/13/22. I had postnasal drip, and nausea. I contacted my doctor and was prescribed 5 days worth of PAXLOVID. My symptoms progressed to a severe sore throat, loss of appetite, fatigue, and laryngitis. After finishing taking PAXLOVID, I had a rebound case and took SUDAFED, ADVIL, and MUCINEX. I am still dealing with these symptoms.
The first week after the shot, I had a red circular dot about 1 inch in diameter. On day 8, it began to bloom and my upper arm was swollen, tender, and inflamed. Over the next few days, the red rash became huge and looked to be the shape of an avocado cut in half, with a dark circular pit at the injection site. At the two week mark, it has become less red but it still itchy and swollen.
No additional AE; a patient was inadvertently administered PROQUAD and VARIVAX concomitantly; This spontaneous report has been received from a nurse referring to a 12 months 29 days patient of unspecified gender. Information of pertinent medical history, concomitant medication and drug reactions/allergies was not reported.  On 29-NOV-2022, the patient was inadvertently administered measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) 0.5 milliliter (mL) subcutaneous injection (0.5 mL, lot# W024551, expiration date 31-JAN-2024, therapy type: rHA, anatomical location and route of administration were unknown) for prophylaxis, and varicella virus vaccine live (oka/merck) (VARIVAX) 0.5 mL subcutaneous injection (0.5 mL, lot# W018824, expiration date 14-JUN-2024, anatomical location and route of administration were unknown) for prophylaxis concomitantly (inappropriate schedule of product administration). No additional adverse event (AE) was reported (no adverse event).
Should have been 0.25 mL as booster dose but administered 0.5 mL or equivalent to 3rd Shot dose.
deltoid myalgia; This is a spontaneous report from a contactable 74-year-old physician reported for himself.  A 74 -year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number EL3249), via Intramuscular route of administration, administered Left arm on 29Jan2021 11:15 AM at a 1st dose, single for COVID-19 immunization. The patient's medical history included DJD, ASHD s/p angioplasty/stent, dyslipidemia, and concomitant medications were not reported. Patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. Patient was not diagnosed with COVID-19 prior to vaccination and patient was not tested for COVID-19 since the vaccination. On 29Jan2021 21:00, patient experienced mild deltoid myalgia. Patient did not receive any treatment for events. Outcome of the events was recovered.  Follow-Up (15-Apr-2021): Follow-up attempts are completed. No further information is expected.
Within hours of getting vaccinated, I developed warmth (several days) and ache (several months) at the injection site and have a residual ache at this time (with direct pressure only, such as when lying down).   The ache made me avoid sleeping on my left side for several weeks as pressure made the situation worse.  This ache did not appear to affect my range of motion so I assumed that the problem would resolve, took OTC antiinflammatory agents and avoided exercises that would irritate the muscle.  In the new year, I began a new exercise program and am surprised that I have weakness and some pain when lifting weights, or when in a position in which I am using my body weight (push up, plank).  I plan to seek a PT evaluation in hopes of resolving the weakness but want to document my problem in case this lot has caused problems with other persons. I am an NP, and can attest that the vaccine was administered properly by the pharmacist.
Wakened from 40 min nap p/DTP given, screaming; mom says pt was not able to be consoled; APAP given x 2, came to office lt thigh warm, slightly red, not indurated; seemed to settle down, then screaming when lt leg moved; f/u call in AM;
pt devel swelling & induration rt forearm w/diff extending the rt wrist;20JAN98 rt arm pain & stiffness;rotator cuff tendinitis noted;impression periph neuropathy vs compression neuropathy;angioedema secondary to vax;lymphedema;
For 72 hour period of 03/29/2021-03/31/2021: 10:30 pm - 06:00 am of 3/29/21 severe large joint aches unresponsive to use of tylenol and motrin; 3/30/31: 11:30 am thru 04:00 am 3/31/21 - "flu like" symptoms: severe chills, body aches, body heat. Craving iced liquids only, decreased appetite; Felt like I had temperatures in high 100's, however, actual oral temp. was 98.2
Patient had itching, mouth swelling, redness around the mouth and felt short of breath. Patient stated the symptoms started at 8 am this morning on 11/19/2021. Patient stated he got his COVID-19 shot on 11/18/2021. He took Allegra and Benadryl this morning on onset of symptoms.  Patient was given a prescription for Kenalog, Aristocort (triamcinolone acetonide) 0.1 % cream and prednisone 20mg tablet to help with allergic reaction symptoms.
little red dots; This case was reported by a consumer via interactive digital media and described the occurrence of red spotty rash in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On 30th October 2021, the patient received the 1st dose of Shingles vaccine. On 31st October 2021, 1 day after receiving Shingles vaccine, the patient experienced red spotty rash. On an unknown date, the outcome of the red spotty rash was unknown.   It was unknown if the reporter considered the red spotty rash to be related to Shingles vaccine.  Additional details were provided are as follows: The case was reported by patient himself/herself. The age at vaccination was not reported. The patient got a dose of vaccine for shingles day before reporting date and on reporting date, saw little red dots on his/her arm. The patient asked that these was ok. The follow-up could not be possible as no contact details were available.
9-11-10 Triathlon - completed 930AM. 9-12-10 Administration of TDAP 1PM Lt deltoid. 9-13-10 7AM 1cm Lt axillary LN enlargement to 1cm & tender & swelling/tenderness Lt supraclavicular region noticeable by 6PM after 3hr swim practice with dry land run cords - started ARTHROTEC 50mg BID then 9-14-10 persistent swelling left supraclavicular area; Lt Ax LN decreased in size. Started MEDROL Dose Pack with ARTHROTEC 75 BID. 9-15-10 7AM swelling decreased supraclavicular region, LN complete resolution Lt Axilla.
Patient experieced dizziness and fainting after receiving the vaccine.  She continued to pass out and regain consciousness repeatedly over a half hour or so.   She experienced sweating, chills, tingling in extremities, and loss of hearing.  She was evaluated by EMS and cleared to go home.
Ma called. Stated child had fever times 3 days, did not take temperature. Pt being followed for (+) PPD. Chest x-ray read on 5/23 dx probable bronchitis. Advised to see physician on 5/30/01. Seen by MD on 5/30. Dx febrile episode? vaccine related. Afebrile times 2 days. Recommended spacing next vaccine 6/1/01. Pt afebrile.
As of 8/4/2021: Hospitalized  She had difficulty speaking and remembering since she was still hospitalized with CO2. Onset about 3 weeks ago, tested 08/02/2021, had severe symptoms including fever, shortness of breath, was admitted, No ICU, Co2, and other meds. She lives with her son and daughter-in-law, they are currently with covid at home, could not remember their information. Has a history of COPD, Osteoporosis, Back issues, etc.
A non-serious report of expired FLUMIST administered was received from a physician concerning an adult patient. Neither medical history nor concomitant medications have been reported. On 01-Nov-2008 and 02-Nov-2008, seventy military personnel, including this patient, received expired FLUMIST vaccine. The vaccine had and expiration date of March 2008. Based on the results of the investigation, the root cause for the medication errors were caused by 1) customers not discarding product from previous season and 2) product expiring during the peak of flu season resulting in some medication errors that occurred shortly after the product expired. There was no adverse event associated with this medication error; therefore, treatment and reporter/sponsor causality assessments are not applicable, and the event is considered resolved. Follow-up information was received on 09-Apr-2009: Product Complaint Investigation results.
About 1 week, Feb. 1,after getting the first vaccine, I started getting a back ache. I had a low grade fever of about 99.8 . Had some sinus issues thought it was allergies. My husband on Thursday, Feb 4 started feeling sick we went and got tested on that day it came back positive. Both of our symptoms were very mild like a mild cold. We lost our taste of smell for about 2 days. Fever lasted maybe 1 day. Felt fine within a week.